Release Date: 30/11/21 08:56 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 750.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%